These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6619039)

  • 1. Effects of mezlocillin on the pharmacokinetics of oxacillin and dicloxacillin.
    Kampf D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():25-32. PubMed ID: 6619039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicloxacillin and cloxacillin: pharmacokinetics in healthy and hemodialysis subjects.
    Nauta EH; Mattie H
    Clin Pharmacol Ther; 1976 Jul; 20(1):98-108. PubMed ID: 1277730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
    Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
    Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the effects of some inducers with or without protein binding properties on bioavailability of isoxazolylpenicillins in rats.
    Couvaris M; Galanopoulou P; Karageorgiou C; Theodosopoulos S; Varonos D
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):187-94. PubMed ID: 3816874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
    Brogard JM; Comte F; Spach MO; Lavillaureix J
    Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal function.
    Kampf D; Schurig R; Bergs A; Förster D
    Clin Nephrol; 1983 Jan; 19(1):37-44. PubMed ID: 6219847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment.
    Mangione A; Boudinot FD; Schultz RM; Jusko WJ
    Antimicrob Agents Chemother; 1982 Mar; 21(3):428-35. PubMed ID: 6213190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of dicloxacillin in healthy subjects of young and old age.
    Löfgren S; Bucht G; Hermansson B; Holm SE; Winblad B; Norrby SR
    Scand J Infect Dis; 1986; 18(4):365-9. PubMed ID: 3764352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mezlocillin pharmacokinetics in renal impairment.
    Aronoff GR; Sloan RS; Luft FC; Nelson RL; Maxwell DR; Kleit SA
    Clin Pharmacol Ther; 1980 Oct; 28(4):523-8. PubMed ID: 6447570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dicloxacillin: a new semisynthetic penicillin. Study of the serum concentrations in comparison with oxacillin].
    Scioli C; Fiorentino F
    Rass Int Clin Ter; 1967 Feb; 47(3):119-24. PubMed ID: 5600881
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)].
    Adam D; Bauer W; Seitz B; Voigt I
    Arzneimittelforschung; 1979; 29(11):1769-804. PubMed ID: 543889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penetration of mezlocillin and oxacillin into the glandular and adipose tissue of the breast after simultaneous intravenous infusion. A pharmacokinetic study].
    Bordt J; Holzgreve W; Wagner H; Adam D
    Geburtshilfe Frauenheilkd; 1983 Jan; 43(1):18-9. PubMed ID: 6219911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic studies with a combination of mezlocillin-oxacillin].
    Adam D; Bauer W
    Arzneimittelforschung; 1979; 29(12a):1971-6. PubMed ID: 543905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of antibiotics and sulfonamides from the human organism during renal insufficiency and the therapeutic consequences].
    Hubmann R
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):154-64. PubMed ID: 4308213
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.